This review highlights that metformin is no longer contraindicated in heart failure patients, correcting a historical misconception regarding lactic acidosis risk.
Answers are grounded in this paper and cite their sources.
Metformin is no longer contraindicated in heart failure; challenges outdated restrictions and reinforces updated guidelines.
The use of metformin was considered a contraindication in heart failure patients because of the potential risk of lactic acidosis; however, more recent evidence has shown that this should no longer be the case. We reviewed the current literature and the recent guideline to correct the misconception.
No takes yet. Share an insight, caveat, or question.
Kinsara et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: